Cic edizioni internazionali
Reviews in Oncology
Last issue of Reviews in Oncology

Reviews in Oncology

Reviews in Oncology, a quarterly, peer-reviewed, open access, on-line journal.

The emphasis will be on promptly publishing quality mini-reviews by taking full advantage of the internet technology for both the submission and review of manuscripts.

All articles published by Reviews in Oncology are made freely and permanently accessible on-line immediately upon publication, without subscription charges or registration request. Full-text of each article is immediately and permanently archived in PubMed Central.

Vol. 3 (No. 1) 2015 January - December

  1. Pregnancy in breast cancer survivors: safety and feasibility
    Stani S.C., Sini V.
    doi: 10.11138/rio/2015.1.5.105

You need to log in or register.

  1. Adjuvant hormone therapy in early breast cancer: aromatase inhibitors and the perimenopausal status
    Moscetti L., Nelli F., Ruggeri E.M.
  2. Endocrine resistance in breast cancer: biological mechanisms and clinical implications to develop new treatment strategies
    Cannita K., Coccolone V., Bruera G., Ficorella C., Ricevuto E.
    doi: 10.11138/rio/2013.1.4.141
  3. Functional imaging with diffusion and perfusion MRI in the evaluation of the response to CHT-RT therapy in head and neck cancer
    Piludu F., Guerrisi A., Izzo G., Marzi S., Vidiri A.
  4. Oligodendroglial tumors: from biology to a better patient care
    Farina P., Lombardi G., Rossetto M., Alentorn A., Sanson M.
  5. Bevacizumab in glioblastomas: lights and shadows
    Spinelli G.P., Stati V., Prete A.A., Lo Russo G., Miele E., Sinjari M., Chiotti M.S., Ciabatta F.R., Rossi B., Tomao S.
    doi: 10.11138/rio/2013.1.4.123
  6. Beyond trastuzumab: what does it?
    Malaguti P., Vari S., Pellegrini D., Fabi A., Cognetti F.
  7. When HER2 inhibition fails: hindering compensatory mechanisms through combinatorial approaches
    Serpico D., Di Cosimo S.
  8. Neo-adjuvant treatment of Her2-positive early breast cancer: standard of care and future directions
    Russillo M., Giovannelli S., Tanganelli L., Baldini E.
  9. Triple negative breast cancer: heterogenous disease
    Scinto A.F.
    doi: 10.11138/rio/2013.1.4.134
  10. Celebrating a new journal
    Cognetti F.